PSNCBAM-1
SIGMA/SML0298 - ≥98% (HPLC)
Synonym: N-(4-Chlorophenyl)-N′-[3-[6-(1-pyrrolidinyl)-2-pyridinyl]phenyl]-urea
CAS Number: 877202-74-9
Empirical Formula (Hill Notation): C22H21ClN4O
Molecular Weight: 392.88
MDL Number: MFCD12756395
Linear Formula: C22H21ClN4O
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C22H21ClN4O/c23-17-9-1 |
| InChI key | HDAYFSFWIPRJSO-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Clc1ccc(NC(=O)Nc2cccc(c2) |
| solubility | DMSO: 15 mg/mL (clear solution) |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | PSNCBAM-1 is an allosteric, non-competitive antagonist of CB-1. |
| Biochem/physiol Actions: | PSNCBAM-1 is an allosteric, non-competitive antagonist of CB-1. The compound blocks the effects of WIN 55212-2 and CP55940, and reduces food intake and weight gain in rats. |
| Features and Benefits: | This compound is featured on the Cannabinoid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 - H319 |
| Precautionary statements | P305 + P351 + P338 |
| Hazard Codes | Xn |
| Risk Statements | 22-36 |
| Safety Statements | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


